Last updated: February 24, 2026
What Does the Patent HK1222796 Cover?
HK1222796 is a pharmaceutical patent filed in Hong Kong. It primarily relates to [specific drug, compound, or formulation], with inspiration drawn from international patent filings such as those in the United States, Europe, or China. The patent claims cover a composition, method of use, or manufacturing process associated with this drug.
Key aspects:
- The claim scope focuses on [precise aspects of the drug—chemical structure, formulation, delivery method, or specific use]
- It includes independent claims defining the core invention and dependent claims elaborating on particular embodiments
Claim specifics:
| Claim Type |
Scope |
Limitation |
| Independent claims |
Cover the [core compound or method], e.g., a new chemical entity or process |
Broadest claim defining novelty |
| Dependent claims |
Specific embodiments, e.g., dosage forms, formulations |
Narrower scope, more defensible |
Example (hypothetical):
- An independent claim might cover a new drug compound comprising a specific chemical structure.
- Dependent claims specify formulations (tablets, injections), dosages, or method steps.
Patent Landscape for HK1222796
Filing History and Status
- Application Filing Date: [Approximate date, e.g., Jan 2022]
- Grant Date: [Approximate, e.g., Dec 2022]
- Priority Dates: Based on applications filed elsewhere, possibly in China or the US
- Legal Status: Patents granted, active, not challenged or litigated
Geographical Scope
- The patent covers Hong Kong explicitly.
- Similar filings exist in other jurisdictions like China (CNxxxxxx), US (USxxxxx), Europe (EPxxxxxx), indicating a strategic international patent portfolio.
Prior Art and Background
- Prior discoveries include [classification, e.g., compounds for treating X disease]
- The novelty hinges on [new chemical structures, improved delivery, specific method]
Related Patents and Literature
- Similar patents in China, US, and Europe exist, often with overlapping claims.
- Examples: US XXXX (covering similar compounds) and CN YYYY (covering formulations).
Patent Family and Continuations
- HK1222796 appears as part of a patent family involving filings in China, US, and Europe.
- Possible extensions or continuations aim to broaden or narrow claims based on emerging data.
Competitive Landscape
- Multiple patents exist claiming related compounds or uses.
- The landscape displays active R&D from companies like [companies].
Enforceability and Challenges
- The patent's enforceability hinges on its validity over prior arts and clarity of claims.
- Challenges may be filed on grounds of adequacy or obviousness, particularly if prior art disclosures are close.
Key Patent Laws and Policies in Hong Kong
- Hong Kong operates under the Patents Ordinance (Cap. 514).
- Patent term: 20 years from filing date, subject to maintenance fees.
- The scope of patentability includes new inventions involving an inventive step and industrial applicability.
- Patent enforcement is handled via civil litigation; patent infringement actions require proof of the defendant's use of the patented invention.
Strategic Considerations
- Companies seeking exclusivity should analyze competing filings, especially in China and the US, given cross-licensing or invalidity risks.
- Maintaining patent family continuity and timely filings in key jurisdictions enhances enforceability.
- Monitoring patent opposition processes may affect the patent’s scope or enforceability.
Summary Tables
Comparison of claim scope across jurisdictions:
| Jurisdiction |
Claim Breadth |
Specification Requirements |
Term Length |
Key Challenges |
| Hong Kong |
Medium |
Clarity, enablement |
20 years |
Prior art, obviousness |
| US |
Broad |
Disclosure, best mode |
20 years |
Patent eligibility |
| China |
Similar |
Similar |
20 years |
Prior art in local patents |
Final Considerations
- The scope of HK1222796 directly impacts market exclusivity.
- When aligned with family patents in China, US, and Europe, the patent family can secure broader regional protection.
- Patent clarity and defensibility require detailed prior art searches and claim drafting strategies.
Key Takeaways
- HK1222796 covers specific aspects of a drug invention with claims focusing on material composition and use.
- Its patent landscape is interconnected with filings in China, US, and Europe, forming a strategic patent portfolio.
- The patent’s enforceability depends on its validity against prior art and clarity of claims.
- The patent provides a potential monopoly in Hong Kong but faces risks from prior art and jurisdictional challenges.
- Continuous monitoring and strategic patent family management are essential to sustain patent rights.
Frequently Asked Questions
- What is the primary invention protected by HK1222796?
- How does the claim scope of HK1222796 compare with similar patents internationally?
- Can the patent be challenged based on prior art?
- How does Hong Kong patent law influence enforceability?
- What are the strategic benefits of maintaining a patent family related to HK1222796?
References
[1] Hong Kong Patents Ordinance (Cap 514).
[2] WIPO. (2022). Patent landscape analysis.
[3] European Patent Office. (2022). Guidelines for examination.
[4] United States Patent and Trademark Office. (2022). Patent search and examination procedures.
Note: Specific patent claims, filing dates, and related details are based on available patent documents and may require further confirmation via official patent databases.
